Aspen Pharmacare
Aspen Pharmacare is a multinational pharmaceutical company headquartered in Durban, South Africa. It is the largest drug company in Africa and has a significant presence in both emerging and developed markets. Aspen Pharmacare is known for its diverse portfolio of products, including branded and generic pharmaceuticals, as well as over-the-counter (OTC) medicines.
History[edit]
Aspen Pharmacare was founded in 1850 as a small business in Port Elizabeth, South Africa. Over the years, it has grown through strategic acquisitions and partnerships. In 1999, Aspen acquired the South African Druggists, which significantly expanded its product range and market reach. The company continued to grow, acquiring several other pharmaceutical companies and product lines, including the acquisition of the global rights to certain products from GlaxoSmithKline in 2009.
Operations[edit]
Aspen Pharmacare operates in more than 50 countries and has over 60 manufacturing facilities across the globe. The company's operations are divided into several business segments, including:
- Branded Pharmaceuticals
- Generic Pharmaceuticals
- Over-the-Counter (OTC) Medicines
- Active Pharmaceutical Ingredients (APIs)
Products[edit]
Aspen's product portfolio includes a wide range of therapeutic categories such as:
Research and Development[edit]
Aspen Pharmacare invests significantly in research and development (R&D) to innovate and improve its product offerings. The company has several R&D facilities worldwide, focusing on developing new formulations and improving existing products.
Corporate Social Responsibility[edit]
Aspen is committed to corporate social responsibility (CSR) and sustainability. The company engages in various initiatives aimed at improving healthcare access, supporting local communities, and reducing its environmental footprint.
Key People[edit]
- Stephen Saad - Co-founder and Group Chief Executive
- Gus Attridge - Co-founder and Deputy Group Chief Executive
See Also[edit]
- Pharmaceutical industry
- Generic drug
- Over-the-counter drug
- Active pharmaceutical ingredient
- GlaxoSmithKline
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
